1. Home
  2. USAS vs NBTX Comparison

USAS vs NBTX Comparison

Compare USAS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$4.50

Market Cap

1.7B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$32.60

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAS
NBTX
Founded
1998
2003
Country
Canada
France
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
USAS
NBTX
Price
$4.50
$32.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$6.50
★ $36.00
AVG Volume (30 Days)
★ 3.5M
114.2K
Earning Date
05-11-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$174.68
$58.17
Revenue Next Year
$53.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.48
$14.78
52 Week High
$10.50
$57.14

Technical Indicators

Market Signals
Indicator
USAS
NBTX
Relative Strength Index (RSI) 40.64 38.64
Support Level $3.57 $32.40
Resistance Level $6.35 $34.66
Average True Range (ATR) 0.25 1.85
MACD -0.07 -0.29
Stochastic Oscillator 2.98 22.51

Price Performance

Historical Comparison
USAS
NBTX

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: